TransCode Therapeutics Reports Second Quarter 2022 Results; Provides Business Update

Go back to TransCode Therapeutics Reports Second Quarter 2022 Results; Provides Business Update
(NASDAQ: RNAZ) Delayed: 4.56 -0.69 (13.14%)
Previous Close $5.25    52 Week High
Open $5.13    52 Week Low
Day High $5.37    P/E N/A 
Day Low $4.47    EPS
Volume 30,255